Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 6
Non-CGM - Third-Class Option .................................................................... 567
Protocol for Maximal Graded Exercise ......................................................... 572
Stress Test Requirements ............................................................................ 572
Protocol for History of Human....................................................................... 573
Immunodeficiency Virus (HIV) Related Conditions ....................................... 573
Protocol for Initial Evaluation of .................................................................... 577
Implanted Pacemaker................................................................................... 577
Protocol for Medication Controlled................................................................ 579
Metabolic Syndrome ..................................................................................... 579
Protocol for Musculoskeletal Evaluation ....................................................... 581
Specifications for Neuropsychological Evaluations for.................................. 583
Potential Neurocognitive Impairment ............................................................ 583
FAA Specifications for Neurologic Evaluation............................................... 585
Protocol for Obstructive Sleep Apnea........................................................... 589
Specifications for Psychiatric Evaluations..................................................... 612
Specifications for Psychiatric and ................................................................. 613
Psychological Evaluations ............................................................................ 613
Six-Minute Walk Test (6MWT) - FAA Result Sheet ...................................... 617
Protocol for Substances of............................................................................ 618
Dependence/abuse (Drugs - Alcohol)........................................................... 618
Protocol for Thromboembolic Disease.......................................................... 619
PHARMACEUTICALS......................................................................................... 620
Pharmaceuticals (Therapeutic Medications)................................................. 626
ALLERGY – ANTIHISTAMINE & IMMUNOTHERAPY MEDICATION .......... 629
ANTACIDS ................................................................................................... 631
ANTICOAGULANTS..................................................................................... 632
EMBOLI MITIGATION IN NON-VALVULAR................................................. 633
ATRIAL FIBRILLATION (AFIB)..................................................................... 633
ANTIDEPRESSANTS................................................................................... 634
ANTIHYPERTENSIVE (HTN, blood pressure medication) .......................... 636
BIOLOGICS, BIOSIMILARS, NON-BIOLOGICS .......................................... 637
CONTRACEPTIVES AND ............................................................................ 641
HORMONE REPLACEMENT THERAPY ..................................................... 641
CONTROLLED SUBSTANCES AND CBD PRODUCTS.............................. 642
COVID-19 MEDICATION.............................................................................. 643
DIABETES MELLITUS - INSULIN TREATED .............................................. 644
DIABETES MELLITUS TYPE II - MEDICATION CONTROLLED (NOT INSULIN)
..................................................................................................................... 645
ACCEPTABLE COMBINATIONS OF DIABETES MEDICATIONS............... 646
ERECTILE DYSFUNCTION AND................................................................. 649
BENIGN PROSTATIC HYPERPLASIA MEDICATIONS............................... 649
EYE MEDICATION....................................................................................... 650
GLAUCOMA AND OCULAR HYPERTENSION MEDICATIONS.................. 651
PLAQUENIL STATUS REPORT .................................................................. 652
MALARIA MEDICATIONS ............................................................................ 653
MIGRAINE MEDICATION ............................................................................ 654
OSTEOPOROSIS MEDICATION ................................................................. 657
OVER-THE-COUNTER MEDICATIONS ...................................................... 658
OVER-THE-COUNTER (OTC) MEDICATIONS REFERENCE GUIDE ........ 660
